Arcutis Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-5.652; its P/E ratio is -1.55; Arcutis Biotherapeutics is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 13.53M	$ 38.11M	$ 5.19M	$ 2.78M	$ 2.96M
Gross Profit	$ 8.54M	$ 38.11M	$ 4.77M	$ 2.78M	-
EBIT	$ -63.91M	$ -31.82M	$ -62.09M	$ -71.49M	$ -65.10M
EBITDA	$ -64.88M	$ -32.87M	$ -63.44M	$ -73.20M	$ -68.63M
Net Income Common Stockholders	$ -66.28M	$ -42.40M	$ -70.99M	$ -80.10M	$ -72.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 271.86M	$ 227.11M	$ 268.67M	$ 333.31M	$ 410.79M
Total Assets	$ 341.37M	$ 292.96M	$ 320.66M	$ 377.36M	$ 449.27M
Total Debt	$ 205.92M	$ 205.07M	$ 204.22M	$ 203.38M	$ 202.54M
Net Debt	$ -65.94M	$ -22.05M	$ -64.45M	$ -129.93M	$ -208.25M
Total Liabilities	$ 252.70M	$ 246.24M	$ 240.18M	$ 239.73M	$ 239.69M
Stockholders Equity	$ 88.67M	$ 46.72M	$ 80.46M	$ 139.70M	$ 209.58M
Cash Flow	-
Free Cash Flow	$ -56.25M	$ -44.05M	$ -66.76M	$ -80.43M	$ -78.69M
Operating Cash Flow	$ -56.24M	$ -43.98M	$ -66.48M	$ -80.34M	$ -71.06M
Investing Cash Flow	$ -62.19M	$ 45.55M	$ 89.12M	$ 107.75M	$ 42.20M
Financing Cash Flow	$ 99.29M	$ 867.00K	$ 1.07M	$ 100.00K	$ 962.00K

Currency in USD

Arcutis Biotherapeutics Earnings and Revenue History

Income Statement >

Arcutis Biotherapeutics Debt to Assets

Balance Sheet >

Arcutis Biotherapeutics Cash Flow

Cash Flow >

Arcutis Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing